 to now stop the randomised phase of the trial and offer the injectable to all the participants. You're saying it's cut short because it's already proved so successful? Correct, exactly that. So we're moving now into what we call the open label phase, where people can choose to use the injectable even if they were assigned to the oral pill arm in the trial. I mean, how successful is successful in this case?